0000899243-19-013250.txt : 20190513 0000899243-19-013250.hdr.sgml : 20190513 20190513170035 ACCESSION NUMBER: 0000899243-19-013250 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190509 FILED AS OF DATE: 20190513 DATE AS OF CHANGE: 20190513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lundbeckfond Invest A/S CENTRAL INDEX KEY: 0001591046 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38886 FILM NUMBER: 19819169 BUSINESS ADDRESS: STREET 1: SCHERFIGSVEJ 7 CITY: COPENHAGEN STATE: G7 ZIP: DK-2100 BUSINESS PHONE: 4540307375 MAIL ADDRESS: STREET 1: SCHERFIGSVEJ 7 CITY: COPENHAGEN STATE: G7 ZIP: DK-2100 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trevi Therapeutics, Inc. CENTRAL INDEX KEY: 0001563880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450834299 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 195 CHURCH STREET STREET 2: 14TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-304-2499 MAIL ADDRESS: STREET 1: 195 CHURCH STREET STREET 2: 14TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-09 1 0001563880 Trevi Therapeutics, Inc. TRVI 0001591046 Lundbeckfond Invest A/S C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, 14TH FLOOR NEW HAVEN CT 06510 0 0 1 0 Common Stock 2019-05-09 4 C 0 776544 A 776544 D Common Stock 2019-05-09 4 P 0 375000 10.00 A 1151544 D Series C Preferred Stock 2019-05-09 4 C 0 6849315 0.00 D Common Stock 776544 0 D On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. /s/ Lene Skole, CEO Lundbeckfond Invest A/S 2019-05-09 /s/ Mette Kirstine Agger, Managing Partner, Lundbeckfonden Ventures 2019-05-09